EnnovaBio

Shanghai, China · Founded 2016 · Privately Held (backing)

Manufacturer of innovative anti-cancer drugs based in Shanghai, China. EnnovaBio is based in Shanghai, China and was founded in 2016. It has raised $24.2 million.

Last price · $/share
—
Implied valuation
—
Total raised
$24.2M
Last round
—

Who backs EnnovaBio?

10 investors
InvestorType
Highlight CapitalOther
Shanghai Healthcare CapitalPE / buyout
Zhangjiang GroupOther
Sailing CapitalVenture capital
KCH Capital Management GroupOther
MPC (Beijing)—
Shanghai Sailing Ruomao Investment—
Sunland Fund—
Yingke Capital—
Yongkan Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

EnnovaBio investors

10 investors are on record for EnnovaBio, including Highlight Capital, Shanghai Healthcare Capital, Zhangjiang Group and Sailing Capital.

Free account
More of EnnovaBio with a free account
  • ·Watch EnnovaBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like EnnovaBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View